Increased aggressiveness of human prostate PC-3 tumor cells expressing cell surface localized membrane type-1 matrix metalloproteinase (MT1-MMP)

Journal of Andrology

Volumn 30, Issue 3, 2009, Pages 259-274

  Wang, Xing ^a   Wilson, Michael J ^a,b,c,d   Slaton, Joel W ^a,c,d   Sinha, Akhouri A ^a,c,d   Ewing, Stephen L ^b,d   Pei, Duanqing ^a,c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d VA MEDICAL CENTER   (United States)

Author keywords

Cancer; Caveolae; Matrix metalloproteinase type 1; MMP 14; Tumor cell invasion; Type I collagen

Indexed keywords

MATRIX METALLOPROTEINASE 14;

AGGRESSIVENESS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INVASION; CARCINOGENESIS; CELL MEMBRANE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FLUORESCENCE ACTIVATED CELL SORTING; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; WILD TYPE;

ANIMALS; BLOTTING, WESTERN; CAVEOLAE; CELL LINE, TUMOR; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOPRECIPITATION; MALE; MATRIX METALLOPROTEINASE 14; MICE; MICE, NUDE; MICROSCOPY, CONFOCAL; NEOPLASM INVASIVENESS; PROSTATIC NEOPLASMS; TRANSFECTION;

EID: 65549140693     PISSN: 01963635     EISSN: None     Source Type: Journal    
DOI: 10.2164/jandrol.108.006494     Document Type: Article

References (50)

1. Anderson RGW, Jacobson K. Role for lipid shells in targeting proteins to caveolae, rafts, and other lipid domains. Science. 2002;296:1821-1825.
2. Annabi B, Lachambre M-P, Bousquet-Gagnon N, Page M. Localization of membrane-type 1 matrix metalloproteinase in caveolae membrane domains. Biochem J. 2001;353:547-553.
3. Annabi B, Thibeault S, Moumdjian R, Beliveau R. Hyaluronan cell surface binding is induced by type I collagen and regulated by caveolae in glioma cells. J Biol Chem. 2004;279:21888-21896.
4. Basbaum CB, Werb Z. Focalized proteolysis: spatial and temporal regulation of extracellular matrix degradation at the cell surface. Curr Opin Cell Biol. 1996;8:731-738.
5. Carmeiet P, Collen D. Development and disease in proteinase-deficient mice: role of the plasminogen, matrix metalloproteinase and coagulation system. Thromb Res. 1998;91:255-285.
6. Conner SD, Schmid SL. Regulated portals of entry into the cell. Nature. 2003;422:37-44.
7. Cui J, Rohr LR, Swanson G, Speights VO, Maxwell T, Brothman AR. Hypermethylation of the caveolin-1 promoter in prostate cancer. Prostate. 2001;46:249-256.
8. Deryugina EI, Soroceanu L, Strongin AY. Up-regulation of vascular endothelial growth factor by membrane-type I matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis. Cancer Res. 2002;62:580-588.
9. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev. 2002;2:161-174.
10. Ellenbroek SM, Stack MS. Membrane associated matrix metalloproteinases in metastasis. Bioessays. 1999;21:940-949.
11. Jemal A, Siegel R, Ward E, Muray T, Xu J, Thun MJ. Cancer statistics, 2007. C A Cancer J Clin. 2007;57:43-66.
12. Jiang A, Lehti K, Wang X, Weiss SJ, Keski-Oja J, Pei D. Regulation of membrane-type matrix metalloproteinase 1 activity by dynamin-mediated endocytosis. Proc Natl Acad Sci U S A. 2001;98: 13693-13698.
13. Jung M, Romer A, Keyszer G, Lein M, Kristiansen G, Schnorr D, Loening SA, Jung K. mRNA expression of the 5 membrane-type matrix metalloproteinases MT1-MT5 in human prostatic cell lines and their down-regulation in human malignant prostatic tissue. Prostate. 2003;55:89-98.
14. Labrecque L, Nyalendo C, Langlois S, Durocher Y, Roghi C, Murphy G, Gringas D, Beliveau R. Src-mediated tyrosine phosphorylation of caveolin-1 induces its association with membrane type 1 matrix metalloproteinase. J Biol Chem. 2004;279:52132-52140.
15. Lisanti MP, Tang ZL, Sargiacomo M. Caveolin forms a hetero-oligomeric protein complex that interacts with an apical GPI-linked protein: implications for the biogenesis of caveolae. J Cell Biol. 1993;123:595-604.
16. Lu ML, Schneider MC, Zheng Y, Zhang X, Richie JP. Caveolin-1 interacts with androgen receptor: a positive modulator of androgen receptor mediated transactivation. J Biol Chem. 2001;276: 13442-13451.
17. Lynch CC, Matrisian LM. Matrix metalloproteinases in tumor-host communication. Differentiation. 2002;70:561-573.
18. Mouraviev V, Li L, Tahir SA, Yang G, Timme TM, Goltsov A, Ren C, Satoh T, Wheeler TM, Ittman MM, Miles BJ, Amato RJ, Kadmon D, Thompson TC. The role of cavolin-1 in androgen insensitive prostate cancer. J Urol. 2002;168:1589-1596.
19. Nemeth JA, Usif R, Herzog M, Che M, Upadhyay J, Shekarriz B, Bhagat S, Mullins C, Fridman R, Cher ML. Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis. J Natl Cancer Inst. 2002;94:17-25.
20. Pettaway CA, Pathak S, Greene G, Ramirez E, Wilson MR, Killion JJ, Fidler IJ. Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice. Clin Cancer Res. 1996;2:1627-1636.
21. Powell WC, Matrisian LM. Complex roles of matrix metalloproteinases in tumor progression. Curr Top Microbiol Immunol. 1996;213:23-31.
22. Puyraimond A, Fridman R, Lemesle M, Arbeille B, Menashi S. MMP2 colocalizes with caveolae on the surface of endothelial cells. Exp Cell Res. 2001;262:28-36.
23. Ramacle A, Murphy G, Roghi C. Membrane type 1-matrix metalloproteinase (MT1-MMP) is internalized by two different pathways and is recycled to the cell surface. J Cell Sci. 2003; 116:3905-3916.
24. Razani B, Lisanti MP. Caveolin-deficient mice: insights into caveolar function and human disease. J Clin Investig. 2001;108:1553-1561.
25. Razani B, Woodman SE, Lisanti MP. Caveolae: from cell biology to animal physiology. Pharmacol Rev. 2002;54:403-431.
26. Rothberg KG, Heuser JE, Donzell WC, Ying YS, Glenney JR, Anderson RG. Caveolin, a protein component of caveolae membrane coats. Cell. 1992;68:673-682.
27. Rozanov DV, Drugina EI, Monosov EZ, Marchenko ND, Srongin AY. Aberrant, persistent inclusion into lipid rafts of membrane type-1 matrix metalloproteinase in malignant cells. Exp Cell Res. 2004; 293:81-95.
28. Rozanov DV, Strongin AY. Membrane type-1 matrix metalloproteinase functions as a proprotein self-convertase.e. J Biol Chem. 2002;278:8257-8260.
29. Seiki M. Membrane-type 1 matrix metalloproteinase: a key enzyme for tumour invasion. Cancer Lett. 2003;194:1-11.
30. Sloan EK, Stanley KL, Anderson RL. Caveolin-1 inhibits breast cancer growth and metastasis. Oncogene. 2004;23:7893-7897.
31. Sounni NE, Devy L, Hajitou A, Frankene F, Munaut C, Gilles C, Deroanne C, Thompson EW, Foidart JM, Noel A. MT1-MMP expression promotes tumor growth and angiogenesis through an up-regulation of vascular endothelial growth factor expression. FASEB J. 2002;16:555-564.
32. Sounni NE, Roghi C, Chabottaux V, Janssen M, Munaut C, Maquoi E, Galvez BG, Gilles C, Frankene F, Murphy G, Fordart JM, Noel A. Up-regulation of vascular endothelial growth factor-A by active membrane-type 1 matrix metalloproteinase through activation of Src-tyrosine kinases. J Biol Chem. 2004;279:13564-13574.
33. Sroka IC, McDaniel K, Nagle RB, Bowden GT. Differential localization of MT1-MMP in human prostate cancer tissue: role of IGF-IR in MT1-MMP expression. Prostate. 2008;68:463-476.
34. Stahl A, Mueller BM. The urokinase-type plasminogen activator receptor, a GPI-linked protein, is localized in caveolae. J Cell Biol. 1995;129:335-344.
35. Stearns M, Stearns ME. Evidence for increased activated metalloproteinase 2 (MMP-2a) expression associated with human prostate cancer progression. Oncol Res. 1996;8:69-75.
36. Stetler-Stevenson WG, Yu AE. Proteases in invasion: matrix metalloproteinases. Cancer Biol. 2001;11:143-152.
37. Thompson TC. Metastasis-related genes in prostate cancer: the role of caveolin-1. Cancer Metastasis Rev. 1998-1999;17:439-442.
38. Udayakumar TS, Chen ML, Bair EL, VonBredow DC, Cress AE, Nagle RB, Bowden GT. Membrane type-1-matrix metalloproteinase expressed by prostate carcinoma cells cleaves human laminin-5 b3 chain and induces cell migration. Cancer Res. 2003;63: 2292-2299.
39. Upadhyay J, Shekarriz R, Nemeth JA, Dong Z, Cummings GD, Fridman R, Sakr W, Grignon DJ, Cher ML. Membrane type 1-matrix metalloproteinase (MT1-MMP) and MMP-2 immunolocalization in human prostate: change in cellular localization associated with high-grade prostatic intraepithelial neoplasia. Clin Cancer Res. 1999;5:4105-4110.
40. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res. 2003;92:827-839.
41. Wang P, Nie J, Pei D. The hemopexin domain of membrane-type matrix metalloproteinase-1 (MT1-MMP) is not required for its activation of proMMP-2 on cell surface but is essential for MT1-MMP-mediated invasion in three-dimensional type I collagen. J Biol Chem. 2004a;279:51148-51155.
42. Wang P, Wang X, Pei D. The hemopexin domain of membrane-type matrix metalloproteinase-1 (MT1-MMP) is not required for its activation of proMMP2 on cell surface but is essential for MT1-MMP-mediated invasion in three-dimensional type I collagen. J Biol Chem. 2004b;279:20461-20470.
43. Williams TM, Hassan GS, Li J, Cohen AW, Mediva F, Frank PG, Pestell RG, DiVizio D, Loda M, Lisanti MP. Caveolin-1 promotes tumor progression in an autochthonous mouse model of prostate cancer. J Biol Chem. 2005;280:25134-25145.
44. Williams TM, Medina F, Badano I, Hazan RB, Hutchinson J, Muller WJ, Chopra NG, Scherer PE, Pestell RG, Lisanti MP. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion. J Biol Chem. 2004;279:51630-51646.
45. Wilson MJ, Jiang A, Wiehr C, Wang X, Sinha AA, Pei D. Limited processing of pro-matrix metalloproteinase-2 (MMP-2, gelatinase A) over expressed by transfection in PC-3 human prostate tumor cells: association with restricted cell surface localization of membrane-type matrix metalloproteinase 1 (MT1-MMP). J Androl. 2004;25:274-285.
46. Wilson MJ, Sinha AA. Human prostate tumor angiogenesis in nude mice: metalloprotease and plasminogen activator activities in neovascularization of subcutaneously injected Matrigel impregnated with human prostate tumor cells. Anat Rec. 1997;249:63-73.
47. Wilson MJ, Sinha AA. Matrix degradation in prostate cancer, In Ablin RJ, Mason MD, eds. Metastasis of Prostate Cancer. Dordrecht, The Netherlands: Springer Science and Business Media BV; 2008:221-251.
48. Zhuang L, Lin J, Lu ML, Solomon KR, Freeman MR. Cholesterol-rich lipid rafts mediate Akt-regulated survival in prostate cancer cells. Cancer Res. 2002;62:2227-2231.
49. Zucker S, Hymowitz M, Conner CE, DiYanni EA, Cao J. Rapid trafficking of membrane type-1 matrix metalloproteinase to the cell surface regulates progelatinase A activation. Lab Investig. 2002;82: 1673-1684.
50. Zucker S, Pei D, Cao J, Lopez-Otin C. Membrane type-matrix metalloproteinases (MT-MMP). Curr Top Dev Biol. 2003;54:1-74.